ライフサイエンスコーパス: AMAN

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します

1 AMAN and AIDP have an immunologic basis, and some cases

2 ed technology in 34 control, 12 AIDP, and 31 AMAN cases.

3 ution of DR13 allelic forms between AIDP and AMAN cases may suggest that there are different immunolo

4 Binding of anti-GD1a mAbs and AMAN sera with anti-GD1a Abs to these derivatives was ex

5 with predominant motor neuropathies such as AMAN.

6 or differentiating the two disease entities (AMAN and AIDP) and focuses our attention on particular D

7 In AMAN patients, alleles DRB1*1301-03 and DRB1*1312, taken

8 neuromuscular junction is a major factor in AMAN.

9 nation for preferential motor axon injury in AMAN.

10 hy (AIDP) and acute motor axonal neuropathy (AMAN) being the most common forms observed.

11 The acute motor axonal neuropathy (AMAN) form of the Guillain-Barre syndrome is a paralytic

12 mpatible with acute motor axonal neuropathy (AMAN) type, and had rapid evolution of disease (median d

13 Campylobacter acute motor axonal neuropathy (AMAN) variant of GBS, and immunization of rabbits with G

14 The acute motor axonal neuropathy (AMAN) variant of Guillain-Barre syndrome (GBS) is associ

15 sociated with acute motor axonal neuropathy (AMAN), a form of Guillain-Barre syndrome that selectivel

16 rre syndrome, acute motor axonal neuropathy (AMAN), and acute motor and sensory axonal neuropathy (AM

17 drome subform acute motor axonal neuropathy (AMAN), Campylobacter jejuni enteritis triggers the produ

18 In acute motor axonal neuropathy (AMAN), the attack appears directed against the axolemma

19 hy (AIDP) and acute motor axonal neuropathy (AMAN).

20 cutoff titer of greater than 1:1,000, 24% of AMAN patients and none of the AIDP patients had IgG anti

21 a cutoff titer of greater than 1:100, 60% of AMAN versus 4% of AIDP patients had IgG anti-GD1a antibo

22 mpylobacter infection was detected in 81% of AMAN and 50% of AIDP patients, and anti-ganglioside anti

23 In 7 fatal cases of AMAN, immunocytochemistry demonstrated the presence of I

24 of rabbits with GM1 has produced a model of AMAN.

25 odies may be involved in the pathogenesis of AMAN.

26 To elucidate the pathophysiology of AMAN, we have developed several monoclonal antibodies (m

27 The GD1a-derivative binding patterns of AMAN sera resembled those with motor-specific mAbs.

28 These results suggest that AMAN is a novel disorder caused by an antibody- and comp

29 tibodies (> 1:100) were detected in both the AMAN and the AIDP forms (57% vs 35%, NS).

30 anti-GM1 (>1:1,000) were more common in the AMAN form (24% vs 8%, NS).

31 The typical AMAN-associated anti-ganglioside antibodies were rarely

32 GD1a antibodies were closely associated with AMAN but not AIDP.

33 II HLA associations were not identified with AMAN, suggesting a different immunological mechanism of

34 g DNA-based typing methods, 47 patients with AMAN, 25 patients with AIDP, and 97 healthy controls wer

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。